Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
6250103 | European Urology Focus | 2015 | 10 Pages |
Abstract
On a population level, the introduction of screening for prostate cancer (PCa) is associated with more men diagnosed but with more favourable disease. The largest screening study confirmed the reduction in death due to PCa. Individual risk estimation is important to best balance the benefits and potential harms of early detection.
Related Topics
Health Sciences
Medicine and Dentistry
Urology
Authors
Roderick C.N. van den Bergh, Stacy Loeb, Monique J. Roobol,